InsidersTradesSigma
Total declarations
Companies
▲ Purchases (7 ops.)
▼ Sales (0 ops.)
Explore the full record of transactions filed by Ehrlich Christopher B, Chief Executive Officer. Insider active across 2 companies, notably eFFECTOR Therapeutics, Inc.. Aggregated, 11 reports have been recorded. Total volume traded: €109k. The latest transaction was filed on 14 February 2022 — Acquisition. Regulator: SEC (Form 4). The full history is openly available.
Declarations11 total
€7,8312,000 shares@ €3.91557.2% of flow
Common Stock
SEC:0001209191-22-011731:0·
Ideal exit: 11 Nov 2022 (T+270)
€4,3001,000 shares@ €4.29968.5% of flow
Common Stock
SEC:0001209191-22-008529·
Ideal exit: 5 Nov 2022 (T+270)
€4,3001,000 shares@ €4.29963.9% of flow
Common Stock
SEC:0001209191-22-008529:0·
Ideal exit: 5 Nov 2022 (T+270)
€22,7885,000 shares@ €4.557545.0% of flow
Common Stock
SEC:0001209191-22-007349·
Ideal exit: 31 Oct 2022 (T+270)
€22,7885,000 shares@ €4.557520.9% of flow
Common Stock
SEC:0001209191-22-007349:0·
Ideal exit: 31 Oct 2022 (T+270)
€23,5825,000 shares@ €4.716546.5% of flow
Common Stock
SEC:0001209191-22-005721·
Ideal exit: 24 Oct 2022 (T+270)
€23,5825,000 shares@ €4.716521.6% of flow
Common Stock
SEC:0001209191-22-005721:0·
Ideal exit: 24 Oct 2022 (T+270)
€317,76636,733 shares@ €8.6507100.0% of flow
Class A common stock
SEC:0000899243-21-039941·
€317,76636,733 shares@ €8.650750.0% of flow
Class A common stock
SEC:0000899243-21-039941:0·
0142,168 shares0
Common Stock
SEC:0001209191-21-053731·
0142,168 shares0
Common Stock
SEC:0001209191-21-053731:0·
11 of 11 declarations
About Ehrlich Christopher B
Christopher B. Ehrlich is the Chief Executive Officer and Secretary of eFFECTOR Therapeutics, Inc. and PHOENIX BIOTECH ACQUISITION CORP. In his roles, he oversees the daily operations and overall strategy of the companies, focusing on innovation in the biotechnology field. His leadership is essential to achieving the growth and development objectives of the firms.
